Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life.
An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Categorical change in T2 lesion volume and clinical outcomes in the Phase III FREEDOMS and its extension study, evaluating fingolimod in patients with relapsing-remitting multiple sclerosis.
Cognitive and patient-reported outcomes in adults with pediatric-onset multiple sclerosis.
Funding Medical Research Projects: Taking into Account Referees' Severity and Consistency through Many-Faceted Rasch Modeling of Projects' Scores.
Multiple sclerosis and pregnancy: a comparison study.
[Familial amyloidotic polyneuropathies].
Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study.
Myoinositol trends in different types of brain lesions.
The Effect of Disease-Modifying Drugs on Brain Atrophy in Relapsing-Remitting Multiple Sclerosis: A Meta-Analysis.
Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination.
Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
Toxicity of cuprizone a Cu(2+) chelating agent on isolated mouse brain mitochondria: a justification for demyelination and subsequent behavioral dysfunction.
Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Interpretation of magnetization transfer from inhomogeneously broadened lines (ihMT) in tissues as a dipolar order effect within motion restricted molecules.
Brain tissue segmentation using fuzzy clustering techniques.
Medications Are Associated with Falls in People with Multiple Sclerosis: A Prospective Cohort Study.
Roche hits multiple sclerosis landmarks.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Impaired growth of the cerebellum in pediatric-onset acquired CNS demyelinating disease.
The Ins and Outs of Polarized Axonal Domains.
Multiple sclerosis-related white matter microstructural change alters the BOLD hemodynamic response.
Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus.
Inducible Expression of CXCL1 within the Central Nervous System Amplifies Viral-Induced Demyelination.
PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation.
Pages
« first
‹ previous
…
618
619
620
621
622
623
624
625
626
…
next ›
last »